- AU$147.28m
- AU$1.18bn
- AU$143.84m
Annual income statement for FSA, fiscal year end - June 30th, AUD millions except per share, conversion factor applied.
2022 June 30th | 2023 June 30th | 2024 June 30th | R2025 June 30th | 2026 June 30th | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 70.3 | 83.7 | 101 | 123 | 144 |
| Cost of Revenue | |||||
| Gross Profit | 58.6 | 55 | 52.4 | 64.5 | 81.5 |
| Selling / General / Administrative Expenses | |||||
| Depreciation and Amortization | |||||
| Operating Interest Expense / Income | |||||
| Other Operating Expenses | |||||
| Total Operating Expenses | 43.3 | 62.8 | 88.4 | 107 | 120 |
| Operating Profit | 26.9 | 21 | 12.6 | 16.2 | 23.9 |
| Net Income Before Taxes | 26.9 | 21 | 12.6 | 16.2 | 23.9 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | 18.7 | 14.8 | 8.82 | 11.2 | 16.7 |
| Minority Interest | |||||
| Net Income Before Extraordinary Items | |||||
| Net Income | 17.2 | 13 | 7.35 | 9.56 | 14.1 |
| Adjustments to Net Income | |||||
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | 17.2 | 13 | 7.35 | 9.56 | 14.1 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | 0.137 | 0.106 | 0.061 | 0.079 | 0.118 |
| Dividends per Share |